Amboy Street Ventures

Amboy Street Ventures is the world's first venture capital fund focused exclusively on sexual health and women's health technology startups, founded in 2021 in Los Angeles, California. The firm closed a $20 million debut fund to invest in seed and Series A stage companies addressing a market opportunity of over $1 trillion in historically underfunded reproductive and women's health categories. Founder Carli Sapir, a former engineer turned investor, built the firm alongside General Partners Dominique Karetsos and Dr. Maria Godoy — both recognised leaders in the women's and sexual health industry. Amboy Street invests and leads rounds with checks of $100,000 to $2 million, targeting cutting-edge startups in fertility, menopause, maternal health, LGBTQ+ health, menstruation, hormonal health, sexual health, and contraception. The portfolio spans 28 investments across healthtech, biotech, and consumer products. The firm adds value beyond capital through a dedicated Value Enhancement Team that supports portfolio companies in marketing and branding, sales and distribution, and product development and scientific innovation. The firm's founding premise is that the systematic underfunding of women's and sexual health represents both a market inefficiency and a societal failure — and that specialised capital, combined with deep domain expertise and commercial networks within healthcare, consumer, and pharmaceutical channels, can correct both simultaneously. Amboy Street Ventures serves as a dedicated backer for founders building in categories that have long been considered taboo or peripheral by mainstream venture investors, despite serving billions of potential customers.